Gynofem Healthcare & Pharmaceuticals Ltd. specializes in women’s healthcare solutions, offering a range of gynecological, fertility, and maternity care products. A strong contender in the pharma sector, this Pre-IPO investment offers access to a growing and socially relevant niche.
| Company Name | Gynofem Healthcare & Pharmaceuticals Ltd. |
|---|---|
| Promoter | Nishi Kant Joshi |
| Est. Year | 2016 |
| Industry | Healthcare - Pharmaceuticals |
| ISIN No | INE0NLL01017 |
| Face Value | ₹1 |
| Website Link | Visit Website ↗ |
Gynofem Healthcare is a leading pharmaceutical company focused on women’s health. With a specialized portfolio catering to gynecology, fertility, and maternity care, it addresses critical health needs through innovation and accessibility.
Gynofem has seen consistent revenue growth, driven by rising awareness around women’s health and increasing demand for niche treatment solutions. It has expanded into both domestic and global markets.
With a rising demand for reproductive health solutions and increasing investment in R&D, Gynofem is well-positioned to capture significant market share in women's healthcare in India and abroad.
| Name | |
|---|---|
| Nishi Kant Joshi | 🔗 Profile |
| Anurag Mendhe | Not Available |
| Kartikay Joshi | Not Available |
Gynofem is revamping its product pipeline with advanced biotech-based formulations aimed at improving treatment outcomes and global appeal.
To improve accessibility, Gynofem is expanding its distribution network in underserved Indian cities, targeting stronger regional market penetration.
